While Astellas’ Veozah was the first neurokinin 3 (NK-3) receptor antagonist approved for menopause, Lynkuet is the first ...

President Donald Trump’s administration released a lengthy review of transgender health care on Thursday that advocates for a greater reliance on behavioral therapy rather than broad gender ...

Bayer receives UK MHRA approval for Lynkuet to treat moderate to severe vasomotor symptoms associated with menopause: Berlin Saturday, July 12, 2025, 10:00 Hrs [IST] Bayer announc ...

Trump’s health agency urges therapy for transgender youth rather than broad gender-affirming health care By Geoff Mulvihill, Clara K. Johnson and Amanda Seitz, Associated Press Published: May 1 ...

President Donald Trump’s administration released a lengthy review of transgender health care on Thursday that advocates for a greater reliance on behavioral therapy rather than broad gender ...

The Trump administration is calling for more reliance on psychotherapy for transgender youth instead of broader gender-affirming medical care.

Trump’s health agency urges therapy for transgender youth, not broader gender-affirming health care The administration’s position sprang from Trump’s executive order calling for the federal government ...

President Donald Trump’s administration released a lengthy review of transgender health care on Thursday that advocates for a greater reliance on behavioral therapy rather than broad gender ...

WASHINGTON — President Donald Trump’s administration released a lengthy review of transgender health care on Thursday that advocates for a greater reliance on behavioral therapy rather than ...

Trump’s health agency urges therapy for transgender youth, not broader gender-affirming health care Major medical groups and those who treat transgender young people sharply criticized the new ...